{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:27:03Z","timestamp":1753892823990,"version":"3.41.2"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003358","name":"Gedeon Richter","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003358","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"Background<\/jats:title>Cariprazine's efficacy and safety have been previously tested in adult patients with acute mania associated with bipolar I disorder, but there is no available data in FEM. The objective of this study is to assess the efficacy and safety of cariprazine in combination with a mood stabilizer in treating FEM as well as to evaluate patients' adherence to the treatment.<\/jats:p><\/jats:sec>Methods<\/jats:title>FEM patients were recruited from the acute inpatient unit at Lleida University Hospital Santa Maria, between January and June 2021. Their symptoms were evaluated using the Young Mania Rating Scale (YMRS) and the Clinical Global Impressions\u2013Severity (CGI-S) scale at admission and at discharge. Akathisia was assessed using the Barnes Akathisia Rating Scale. Patient adherence to medication treatment was assessed 30 days after discharge using the Morisky, Green and Levine Medication Adherence Scale. Socio-demographic and clinical information were further collected.<\/jats:p><\/jats:sec>Results<\/jats:title>Eleven patients with FEM were involved, seven women and four men. Their mean age was 26.00+\/-6.37 years. Mean hospitalization was 17.36+\/\u22124.7 days. Cariprazine was combined with a mood stabilizer: lithium in seven patients and divalproex in four. Mean YMRS change from baseline was \u221224.55+\/\u22127.5 and the mean CGI-S change from baseline was \u22122.55+\/\u22120.82. Regarding adverse events, two (18.2%) patients presented with akathisia. At the 30-day treatment-adherence assessment, six (54.5%) patients were adherent and four (36.4%) had moderate adherence.<\/jats:p><\/jats:sec>Conclusion<\/jats:title>In this sample, cariprazine in combination with mood stabilizers proved to be safe and effective in the treatment of FEM with more than half the patients being adherent to treatment. Therefore, cariprazine add-on is a good choice for promoting the long-term adherence of patients, thus minimizing the risk of relapse and improving prognosis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2022.828088","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T05:57:55Z","timestamp":1652248675000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Cariprazine Use in Combination With a Mood Stabilizer in First Episode Mania"],"prefix":"10.3389","volume":"13","author":[{"given":"Roberto","family":"Palacios-Garr\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicent","family":"Llorca-Bof\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gara","family":"Arteaga-Henriquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"del Agua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1016\/j.euroneuro.2015.08.020","article-title":"Effect of cariprazine across the symptoms of mania in bipolar I disorder: analyses of pooled data from phase II\/III trials","volume":"25","author":"Vieta","year":"2015","journal-title":"Euro Neuropsychopharmacol"},{"key":"B2","unstructured":"Bipolar disorders116\n VietaE\n BerkM\n SchulzeTG\n CarvalhoAF\n SuppesT\n alabreseJR\n Nat Rev Dis Prim.42018"},{"key":"B3","unstructured":"Diagnostic and Statistical Manual of Mental Disorders (DSM\u22125) [Internet]2013"},{"key":"B4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.31887\/DCNS.2008.10.2\/evieta","article-title":"Acute and long-term treatment of mania","volume":"10","author":"Vieta","year":"2008","journal-title":"Dialog Clin Neurosci"},{"key":"B5","unstructured":"Bipolar disorder156172\n GrandeI\n BerkM\n BirmaherB\n VietaE\n Lancet3872016"},{"key":"B6","unstructured":"The 2020 royal australian and new zealand college of psychiatrists clinical practice guidelines for mood disorders: bipolar disorder summary80521\n MalhiGS\n BellE\n BoyceP\n BassettD\n BerkM\n BryantR\n 33706410Bipolar Disord222020"},{"key":"B7","unstructured":"Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder97170\n YathamLN\n KennedySH\n ParikhSV\n SchafferA\n BondDJ\n FreyBN\n 29536616Bipolar Disord202018"},{"key":"B8","unstructured":"How to treat mania17392\n PacchiarottiI\n AnmellaG\n ColomerL\n VietaE\n Acta Psychiatrica Scandinavica1422020"},{"key":"B9","unstructured":"Lithium: still a major option in the management of bipolar disorder21926\n LichtRW\n 22070642CNS Neurosci Therapeutics182012"},{"key":"B10","unstructured":"Mood stabilizers and antipsychotics for acute mania: a systematic review and meta-analysis of combination\/augmentation therapy vs. monotherapy9891003\n OgawaY\n TajikaA\n TakeshimaN\n HayasakaY\n FurukawaTA\n 25160685CNS Drugs282014"},{"key":"B11","unstructured":"A narrative review of intervention in first-episode affective psychoses12337\n RamainJ\n ConusP\n GolayP\n 34487989J Psych Res1432021"},{"key":"B12","unstructured":"Bipolar disorders184156\n McIntyreRS\n BerkM\n BrietzkeE\n GoldsteinBI\n L\u00f3pez-JaramilloC\n KessingLV\n Lancet3962020"},{"key":"B13","unstructured":"Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants: a randomized, double-blind, placebo-controlled study in adult patients with major depressive disorder3718\n DurgamS\n EarleyW\n GuoH\n LiD\n N\u00e9methG\n LaszlovszkyI\n 27046309J Clin Psych772016"},{"key":"B14","unstructured":"Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)\/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile32840\n KissB\n Horv\u00e1thA\n N\u00e9methyZ\n Schmidt\u00c9\n LaszlovszkyI\n BugovicsG\n 200933973332010"},{"key":"B15","unstructured":"Mechanism of action of cariprazine1237\n StahlSM\n CNS Spectrums212016"},{"key":"B16","unstructured":"The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial6375\n DurgamS\n StaraceA\n LiD\n MiglioreR\n RuthA\n N\u00e9methG\n 25056368172015"},{"key":"B17","unstructured":"Cariprazine in the treatment of acute mania in bipolar I disorder: a double-blind, placebo-controlled, phase III trial296302\n SachsGS\n GreenbergWM\n StaraceA\n LuK\n RuthA\n LaszlovszkyI\n 25532076J Aff Disord1742015"},{"key":"B18","unstructured":"Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: a double-blind, placebo-controlled study28492\n CalabreseJR\n KeckPE\n StaraceA\n LuK\n RuthA\n LaszlovszkyI\n 25562205J Clin Psych762015"},{"key":"B19","unstructured":"The safety and tolerability of cariprazine in patients with manic or mixed episodes associated with bipolar I disorder: a 16-week open-label study3506\n KetterTA\n SachsGS\n DurgamS\n LuK\n StaraceA\n LaszlovszkyI\n 28843918J Aff Disord2252018"},{"key":"B20","unstructured":"Vraylar (cariprazine) [package insert]2015"},{"key":"B21","unstructured":"Cariprazine-induced mania: a case series report\n Pons-CabreraMT\n Palacios-Garr\u00e1nR\n Tard\u00f3n-SenabreL\n Fern\u00e1ndez-PlazaT\n Marco-EstradaO\n MaderoS\n 34797609Bipolar Disord2021"},{"key":"B22","unstructured":"Cariprazine as a treatment across the bipolar I spectrum from depression to mania: mechanism of action and review of clinical data2045125320905752\n StahlSM\n LaredoS\n MorrissetteDA\n 32110377Therap Adv Psychopharmacol102020"},{"key":"B23","unstructured":"Real-world evidence and real-world data for evaluating drug safety and effectiveness8678\n Corrigan-CurayJ\n SacksL\n WoodcockJ\n 30105359JAMA3202018"},{"key":"B24","unstructured":"Real-world evidence - what is it and what can it tell us?22937\n ShermanRE\n AndersonSA\n Dal PanGJ\n GrayGW\n GrossT\n HunterNL\n N Eng J Med3752016"},{"key":"B25","unstructured":"The utility of real-world evidence for benefit-risk assessment, communication, and evaluation of pharmaceuticals: case studies15329\n RadawskiCA\n HammadTA\n ColillaS\n CoplanP\n HornbuckleK\n FreemanE\n 33146901Pharmacoepidemiol Drug Safety292020"},{"key":"B26","unstructured":"A rating scale for mania: reliability, validity and sensitivity42935\n YoungRC\n BiggsJT\n ZieglerVE\n MeyerDA\n 728692Br J Psychiatry : J Mental Sci1331978"},{"key":"B27","unstructured":"Spanish version of a scale for the assessment of mania: validity and reliability of the young mania rating scale36671\n ColomF\n VietaE\n Mart\u00ednez-Ar\u00e1nA\n Garcia-GarciaM\n ReinaresM\n TorrentC\n 12372167Medicina Clinica1192002"},{"key":"B28","doi-asserted-by":"crossref","unstructured":"How to assess drugs in the treatment of acute bipolar mania?4\n BourinM\n ThibautF\n 23372551Front Pharmacol2013","DOI":"10.3389\/fphar.2013.00004"},{"key":"B29","unstructured":"Tolerability of cariprazine in the treatment of acute bipolar I mania: a pooled post-hoc analysis of 3 phase II\/III studies20512\n EarleyW\n DurgamS\n LuK\n DebelleM\n LaszlovszkyI\n VietaE\n 28343051J Aff Disord2152017"},{"key":"B30","unstructured":"A rating scale for drug-induced akathisia6726\n BarnesTRE\n Br J Psych : J Mental Sci1541989"},{"key":"B31","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.eurpsy.2009.01.005","article-title":"Cardiovascular disease and diabetes in people with severe mental illness position statement from the European psychiatric association (EPA), supported by the European association for the study of diabetes (EASD) and the European society of cardiology (ESC)","volume":"24","author":"de Hert","year":"2009","journal-title":"Eur Psych"},{"key":"B32","unstructured":"Concurrent and predictive validity of a self-reported measure of medication adherence6774\n MoriskyDE\n GreenLW\n LevineDM\n 3945130Med Care241986"},{"key":"B33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jad.2017.09.040","article-title":"Clinically relevant response and remission outcomes in cariprazine-treated patients with bipolar I disorder","volume":"226","author":"Earley","year":"2018","journal-title":"J Affect Disord."},{"key":"B34","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3389\/fpsyt.2018.00641","article-title":"Toward precision psychiatry in bipolar disorder: staging 20","volume":"9","author":"Salagre","year":"2018","journal-title":"Front Psychiatry."},{"key":"B35","unstructured":"Intervening early in bipolar disorder in young people: a review of the clinical staging model3143\n PowerP\n 30185268Irish J Psychol Med322015"},{"key":"B36","unstructured":"Recurrence of bipolar disorders and major depression. A life-long perspective23640\n AngstJ\n GammaA\n SellaroR\n LavoriPW\n ZhangH\n 14504992Eur Arc Psychiatry Clin Neurosci2532003"},{"key":"B37","doi-asserted-by":"crossref","unstructured":"Identifying profiles of patients with bipolar i disorder who would benefit from maintenance therapy with a long-acting injectable antipsychotic81\n TohenM\n GoldbergJF\n HassounY\n SureddiS\n 32558403J Clin Psych2020","DOI":"10.4088\/JCP.OT19046AH1"},{"key":"B38","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.comppsych.2008.06.008","article-title":"Predictors of non-adherence among individuals with bipolar disorder receiving treatment in a community mental health clinic","volume":"50","author":"Sajatovic","year":"2009","journal-title":"Compreh Psych"},{"key":"B39","unstructured":"Medication non-adherence in bipolar disorder: a narrative review34963\n JawadI\n WatsonS\n HaddadPM\n TalbotPS\n McAllister-WilliamsRH\n 30524703Therap Adv Psychopharmacol82018"},{"key":"B40","unstructured":"EPAR for Reagila2017"},{"key":"B41","unstructured":"Lipids and Lipoproteins4078\n MeeusenJ\n UedaM\n NordestgaardB\n RemaleyA\n Textbook of Laboratory Medicine [Internet]2023"},{"key":"B42","unstructured":"Effects of cariprazine on prolactin levels in patients with bipolar I disorder conclusions background\n PatelM\n CulpepperL\n VietaE\n KellyDL\n MoreiraT\n EarleyW\n 32nd Annual Psych Congress2019"},{"key":"B43","unstructured":"Psychotic symptoms in patients with bipolar mania1649\n CanusoCM\n BossieCA\n ZhuY\n YoussefE\n DunnerDL\n 23189939J Aff Disord112008"},{"key":"B44","unstructured":"Psychopharmacological treatment of psychotic mania and psychotic bipolar depression compared to non-psychotic mania and non-psychotic bipolar depression50512\n Bj\u00f8rklundLB\n HorsdalHT\n MorsO\n GasseC\n \u00d8stergaardSD\n 28593691Bipolar Disord192017"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.828088\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T05:58:03Z","timestamp":1652248683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.828088\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,11]]},"references-count":44,"alternative-id":["10.3389\/fpsyt.2022.828088"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2022.828088","relation":{},"ISSN":["1664-0640"],"issn-type":[{"type":"electronic","value":"1664-0640"}],"subject":[],"published":{"date-parts":[[2022,5,11]]},"article-number":"828088"}}